DLL4 Antikörper
(3 Referenzen)-
- Target Alle DLL4 Antikörper anzeigen
- DLL4 (delta-Like 4 (DLL4))
-
Reaktivität
- Human, Maus, Ratte, Schimpanse
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DLL4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Schimpanse, Maus, Ratte (Rattus)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Isotyp
- IgG
- Top Product
- Discover our top product DLL4 Primärantikörper
-
anti-delta-Like 4 (DLL4) antibody
DLL4 Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 4A11 unconjugated
anti-delta-Like 4 (DLL4) (AA 313-439) antibodyDLL4 Reaktivität: Human WB, ELISA, IHC Wirt: Maus Monoclonal 4A11F8 unconjugated
anti-delta-Like 4 (DLL4) (AA 215-331) antibodyDLL4 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-delta-Like 4 (DLL4) (Internal Region) antibodyDLL4 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-delta-Like 4 (DLL4) (AA 625-652), (C-Term) antibodyDLL4 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB23696 unconjugated
anti-delta-Like 4 (DLL4) antibodyDLL4 Reaktivität: Maus, Ratte IHC Wirt: Kaninchen Polyclonal unconjugated
anti-delta-Like 4 (DLL4) antibodyDLL4 Reaktivität: Human WB, EIA Wirt: Maus Monoclonal 4A11F8-4A11G2 unconjugated
anti-delta-Like 4 (DLL4) antibodyDLL4 Reaktivität: Human FACS Wirt: Maus Monoclonal MHD4-46 unconjugated
anti-delta-Like 4 (DLL4) antibodyDLL4 Reaktivität: Human FACS, Func Wirt: Maus Monoclonal MHD4-46 unconjugated
anti-delta-Like 4 (DLL4) (AA 44-345) antibodyDLL4 Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
-
-
: "Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations." in: Journal of cellular and molecular medicine, Vol. 17, Issue 3, pp. 407-18, (2013) (PubMed).
: "Multiple biomarker tissue arrays: A computational approach to identifying protein-protein interactions in the EGFR/ERK signalling pathway." in: Journal of molecular signaling, Vol. 7, Issue 1, pp. 14, (2012) (PubMed).
: "The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth." in: Nature reviews. Cancer, Vol. 7, Issue 5, pp. 327-31, (2007) (PubMed).
-
: "Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations." in: Journal of cellular and molecular medicine, Vol. 17, Issue 3, pp. 407-18, (2013) (PubMed).
-
- Target
- DLL4 (delta-Like 4 (DLL4))
- Andere Bezeichnung
- delta-LIKE PROTEIN 4 (DLL4 Produkte)
- Synonyme
- hdelta2 antikoerper, Delta4 antikoerper, si:ch211-244p18.5 antikoerper, zgc:136596 antikoerper, delta like canonical Notch ligand 4 antikoerper, delta-like 4 (Drosophila) antikoerper, DLL4 antikoerper, Dll4 antikoerper, dll4 antikoerper
- Hintergrund
- Synonyms: DLL4
- Gen-ID
- 54567
- UniProt
- Q9NR61
- Pathways
- Notch Signalweg
-
